Enforcement and administrative action
Administrative Guidance disclosure naming 公益社団法人日本消費生活アドバイザー・コンサルタント・相談員協会
The published name has not been matched to a verified Corporate Number. Check the identity before attributing this record to a company.
- Action type
- Administrative Guidance
- Law
- Pharmaceutical Affairs Act
- Authority
- Ministry of Health, Labour and Welfare
- Action date
- 8 March 2017
Published details
Conducting a hearing regarding the review of handling over-the-counter drugs when pharmacists are absent at pharmacies.
Machine-translated from the Japanese disclosure. The original Japanese text is available below.
Sources and saved materials
Review the source list, printable report and available saved files.
Evidence pack ¥4,980tax included · one-time purchase
Available PDFs, images and other files vary by record. Check the included materials before purchasing; a source URL does not guarantee an original file is included.
Purchase and download pages are currently in Japanese. Materials retain the original source language.
Official source URL recorded · Queued for preservation
Source links and saved files require purchase. Already purchased?
Action details
- Industry (as published)
- 消費者団体
Show original Japanese text
薬局における薬剤師不在時の一般用医薬品の取扱いの見直しに係るヒアリングを行います
Sources, saved materials and verification
Source verification
Public-source and preservation status
- Publishing authority
- Ministry of Health, Labour and Welfare
- Official source URL
- Recorded by RegBase
- Entity match
- Not confirmed; shown under the published name
- Kiroku preservation
- Queued for preservation
“Confirmed” means that RegBase matched this record to the cited public disclosure or entity under the stated checks. It does not verify the truth of the disclosure or guarantee the entity’s current status, creditworthiness, or any legal conclusion.
Open Sources and saved materials on this page to review the available pack contents.
About this action and law
Administrative guidance or supervision was publicly disclosed by the authority.
Japanese regulatory disclosure under Pharmaceutical Affairs Act.
Use as a monitoring signal. Confirm details before treating it as a formal sanction.
English translations are for reference. Verify important decisions against the original Japanese disclosure. View the Japanese page.